• Buradasın

    Johnson & Johnson Company Analysis

    komalkamble01.medium.com/company-analysis-johnson-johnson-83f26466f851

    Yapay zekadan makale özeti

    Company Overview
    • Founded in 1887, J&J operates in 60 countries with 132,200 employees worldwide
    • Company has 97 manufacturing facilities totaling 15.2 million square feet
    • Ranked 37th on 2019 Fortune 500 list
    Business Segments
    • Three main segments: Consumer, Pharmaceuticals, and Medical Devices
    • Pharmaceuticals segment generated $42.2B in 2019, accounting for 51.4% of total sales
    • Medical Devices segment generated $26B in 2019, accounting for 31.6% of total sales
    • Consumer segment includes major brands like Johnson's, Listerine, and Tylenol
    Research and Development
    • Spends over $10 billion annually on R&D globally
    • Commercialized over $20 billion worth of new products in past five years
    • Has 14 approved drugs since 2011, generating over $1 billion each
    • Expects 40-50 new medical device launches by 2022
    Financial Performance
    • Worldwide sales grew 0.6% to $82.1B in 2019
    • Completed 13 major acquisitions and 100 innovation deals in 2019
    • Maintains 35 consecutive years of earnings growth
    • Dividend increases 44.78% over 56 years
    COVID-19 Response
    • Committed over $1 billion to COVID-19 vaccine development
    • Increased Tylenol production globally during pandemic
    • Developed VESper Ventilator Expansion Splitter for ventilator shortage
    • Expected to start COVID-19 vaccine clinical trials in September 2020

    Yanıtı değerlendir

  • Yazeka sinir ağı makaleleri veya videoları özetliyor